Trial Profile
Two Randomized, Open-labeled, Parallel Designed Multiple-dose Clinical Trials to Evaluate Pharmacokinetics of Ritonavir-unboosted and Ritonavir-boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 10 Jun 2011 New trial record